Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.42
Tweet
Share
E-mailGet Alerts RAPP Hot Sheet
Join SI Premium – FREE
Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.42). Revenue for the quarter came in at $20 million.
For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Madrigal Pharma (MDGL) Tops Q2 EPS by 76c
- ExxonMobil Q2 profit falls short of forecasts, shares slide
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
